MyMD Pharmaceuticals Ownership 2024 | Who Owns MyMD Pharmaceuticals Now?


OverviewFinancialsChart

Institutional Ownership

0.01%

Insider Ownership

6.85%

Retail Ownership

93.14%

Institutional Holders

2.00

MyMD Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
VANGUARD GROUP INC32.80%0.00%1,458,295--2,508,267,000Mar 31, 2023
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.26.40%0.00%1,173,610417,12555.14%2,018,609,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC6.21%0.00%276,298--475,232,000Mar 31, 2023
BLACKROCK INC.4.60%-204,6577,3363.72%352,010,000Mar 31, 2023
STATE STREET CORP2.70%-120,25218,50018.18%206,833,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP2.22%-98,59227,02637.76%169,578,000Mar 31, 2023
WELLS FARGO & COMPANY/MN1.69%-75,21675,00435379.25%129,372,000Mar 31, 2023
CITADEL ADVISORS LLC1.67%-74,200-31,000-29.47%127,624,000Mar 31, 2023
M HOLDINGS SECURITIES, INC.1.59%0.01%70,909--122,000Mar 31, 2023
CAMBRIA INVESTMENT MANAGEMENT, L.P.1.39%0.01%61,956-6,884-10.00%106,564,000Mar 31, 2023
NORTHERN TRUST CORP1.35%-60,0904,7348.55%103,355,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.92%-40,90040,900100.00%70,348,000Mar 31, 2023
FIDELIS CAPITAL PARTNERS, LLC0.87%0.03%38,590--64,831,000Mar 31, 2023
MORGAN STANLEY0.85%-37,967-147,728-79.55%65,303,000Mar 31, 2023
CITADEL ADVISORS LLC0.78%-34,8001,6004.82%59,856,000Mar 31, 2023
GROUP ONE TRADING, L.P.0.74%0.00%33,10032,3004037.50%56,932,000Mar 31, 2023
GROUP ONE TRADING, L.P.0.71%0.00%31,70724,947369.04%54,536,000Mar 31, 2023
BANK OF AMERICA CORP /DE/0.67%-30,001-7,763-20.56%51,602,000Mar 31, 2023
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.0.59%0.00%26,0231,2234.93%44,760,000Mar 31, 2023
PARALLEL ADVISORS, LLC0.57%0.00%25,12525,125100.00%43,215,000Mar 31, 2023

MyMD Pharmaceuticals's largest institutional shareholder is VANGUARD GROUP INC, holding 32.80% of the company's total share outstanding, currently valued at $2.51B. The top 10 institutional shareholders own together 81.29% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FIDELIS CAPITAL PARTNERS, LLC0.87%0.03%38,590--64,831,000Mar 31, 2023
TAYLOR & MORGAN WEALTH MANAGEMENT, LLC0.36%0.02%16,086-1,000-5.85%27,668,000Mar 31, 2023
CORUNDUM GROUP, INC.0.44%0.02%19,600--33,712,000Mar 31, 2023
PRAETORIAN WEALTH MANAGEMENT, INC.0.56%0.01%25,000--43,000,000Mar 31, 2023
M HOLDINGS SECURITIES, INC.1.59%0.01%70,909--122,000Mar 31, 2023
CAMBRIA INVESTMENT MANAGEMENT, L.P.1.39%0.01%61,956-6,884-10.00%106,564,000Mar 31, 2023
BRIDGECREEK INVESTMENT MANAGEMENT, LLC0.34%0.01%15,000--25,800,000Mar 31, 2023
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.26.40%0.00%1,173,610417,12555.14%2,018,609,000Mar 31, 2023
NWAM LLC0.56%0.00%25,00025,000100.00%43,000,000Mar 31, 2023
SEACREST WEALTH MANAGEMENT, LLC0.29%0.00%12,85012,850100.00%22,102,000Mar 31, 2023
PARALLEL ADVISORS, LLC0.57%0.00%25,12525,125100.00%43,215,000Mar 31, 2023
KESTRA PRIVATE WEALTH SERVICES, LLC0.27%0.00%12,10012,100100.00%20,812,000Mar 31, 2023
ST. JOHNS INVESTMENT MANAGEMENT COMPANY, LLC0.01%0.00%494--850,000Mar 31, 2023
SIMPLICITY SOLUTIONS, LLC0.22%0.00%10,00010,000100.00%17,200,000Mar 31, 2023
SANDY SPRING BANK0.08%0.00%3,460--5,952,000Mar 31, 2023
LEVEL FINANCIAL ADVISORS, INC.0.00%0.00%200200100.00%344,000Mar 31, 2023
GROUP ONE TRADING, L.P.0.74%0.00%33,10032,3004037.50%56,932,000Mar 31, 2023
GROUP ONE TRADING, L.P.0.71%0.00%31,70724,947369.04%54,536,000Mar 31, 2023
ANCORA ADVISORS, LLC0.06%0.00%2,700--4,644,000Mar 31, 2023
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.0.59%0.00%26,0231,2234.93%44,760,000Mar 31, 2023

The largest MyMD Pharmaceuticals shareholder by % of total assets is FIDELIS CAPITAL PARTNERS, LLC. The company owns 38.59K shares of MyMD Pharmaceuticals (MYMD), representing 0.03% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.26.40%0.00%1,173,610417,12555.14%2,018,609,000Mar 31, 2023
WELLS FARGO & COMPANY/MN1.69%-75,21675,00435379.25%129,372,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.92%-40,90040,900100.00%70,348,000Mar 31, 2023
GROUP ONE TRADING, L.P.0.74%0.00%33,10032,3004037.50%56,932,000Mar 31, 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP2.22%-98,59227,02637.76%169,578,000Mar 31, 2023
PARALLEL ADVISORS, LLC0.57%0.00%25,12525,125100.00%43,215,000Mar 31, 2023
NWAM LLC0.56%0.00%25,00025,000100.00%43,000,000Mar 31, 2023
GROUP ONE TRADING, L.P.0.71%0.00%31,70724,947369.04%54,536,000Mar 31, 2023
STATE STREET CORP2.70%-120,25218,50018.18%206,833,000Mar 31, 2023
COMMONWEALTH EQUITY SERVICES, LLC0.38%0.00%17,04417,044100.00%29,000Mar 31, 2023
CI PRIVATE WEALTH, LLC0.34%0.00%15,00015,000100.00%25,800,000Mar 31, 2023
SEACREST WEALTH MANAGEMENT, LLC0.29%0.00%12,85012,850100.00%22,102,000Mar 31, 2023
KESTRA PRIVATE WEALTH SERVICES, LLC0.27%0.00%12,10012,100100.00%20,812,000Mar 31, 2023
GROUP ONE TRADING, L.P.0.28%0.00%12,50011,4001036.36%21,500,000Mar 31, 2023
SIMPLICITY SOLUTIONS, LLC0.22%0.00%10,00010,000100.00%17,200,000Mar 31, 2023
SIMPLEX TRADING, LLC0.36%-16,0629,864159.15%27,000Mar 31, 2023
BLACKROCK INC.4.60%-204,6577,3363.72%352,010,000Mar 31, 2023
NORTHERN TRUST CORP1.35%-60,0904,7348.55%103,355,000Mar 31, 2023
SIMPLEX TRADING, LLC0.14%-6,0004,000200.00%10,000Mar 31, 2023
SIMPLEX TRADING, LLC0.17%-7,4002,00037.04%12,000Mar 31, 2023

As of Mar 31 2023, MyMD Pharmaceuticals's largest institutional buyer is MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.. The company purchased 417.13K stocks of MYMD, valued at $2.02B.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SHAY CAPITAL LLC----207,235-100.00%-Mar 31, 2023
MORGAN STANLEY0.85%-37,967-147,728-79.55%65,303,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----68,312-100.00%-Mar 31, 2023
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC----67,000-100.00%-Mar 31, 2023
CITADEL ADVISORS LLC1.67%-74,200-31,000-29.47%127,624,000Mar 31, 2023
TWO SIGMA INVESTMENTS, LP----30,084-100.00%-Mar 31, 2023
WOLVERINE TRADING, LLC----19,600-100.00%-Mar 31, 2023
BANK OF AMERICA CORP /DE/0.67%-30,001-7,763-20.56%51,602,000Mar 31, 2023
UBS GROUP AG----7,312-100.00%-Mar 31, 2023
CAMBRIA INVESTMENT MANAGEMENT, L.P.1.39%0.01%61,956-6,884-10.00%106,564,000Mar 31, 2023
CITADEL ADVISORS LLC0.11%-4,864-4,808-49.71%8,366,000Mar 31, 2023
TAYLOR & MORGAN WEALTH MANAGEMENT, LLC0.36%0.02%16,086-1,000-5.85%27,668,000Mar 31, 2023
GENEOS WEALTH MANAGEMENT INC.0.01%0.00%500-225-31.03%860,000Mar 31, 2023
IFP ADVISORS, INC----2-100.00%-Mar 31, 2023
FIDELIS CAPITAL PARTNERS, LLC0.87%0.03%38,590--64,831,000Mar 31, 2023
CORUNDUM GROUP, INC.0.44%0.02%19,600--33,712,000Mar 31, 2023
PRAETORIAN WEALTH MANAGEMENT, INC.0.56%0.01%25,000--43,000,000Mar 31, 2023
M HOLDINGS SECURITIES, INC.1.59%0.01%70,909--122,000Mar 31, 2023
BRIDGECREEK INVESTMENT MANAGEMENT, LLC0.34%0.01%15,000--25,800,000Mar 31, 2023
ST. JOHNS INVESTMENT MANAGEMENT COMPANY, LLC0.01%0.00%494--850,000Mar 31, 2023

As of Mar 31 2023, MyMD Pharmaceuticals's biggest institutional seller is SHAY CAPITAL LLC. The company sold -0.21M shares of MYMD, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.92%-40,90040,900100.00%70,348,000Mar 31, 2023
PARALLEL ADVISORS, LLC0.57%0.00%25,12525,125100.00%43,215,000Mar 31, 2023
NWAM LLC0.56%0.00%25,00025,000100.00%43,000,000Mar 31, 2023
COMMONWEALTH EQUITY SERVICES, LLC0.38%0.00%17,04417,044100.00%29,000Mar 31, 2023
CI PRIVATE WEALTH, LLC0.34%0.00%15,00015,000100.00%25,800,000Mar 31, 2023
SEACREST WEALTH MANAGEMENT, LLC0.29%0.00%12,85012,850100.00%22,102,000Mar 31, 2023
KESTRA PRIVATE WEALTH SERVICES, LLC0.27%0.00%12,10012,100100.00%20,812,000Mar 31, 2023
SIMPLICITY SOLUTIONS, LLC0.22%0.00%10,00010,000100.00%17,200,000Mar 31, 2023
FMR LLC0.02%-1,0001,000100.00%1,720,000Mar 31, 2023
ROYAL BANK OF CANADA0.02%-913913100.00%2,000,000Mar 31, 2023
JPMORGAN CHASE & CO0.01%-347347100.00%1,000,000Mar 31, 2023
STRATEGIC INVESTMENT SOLUTIONS, INC. /IL0.00%0.00%200200100.00%344,000Mar 31, 2023
LEVEL FINANCIAL ADVISORS, INC.0.00%0.00%200200100.00%344,000Mar 31, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO0.00%-7474100.00%127,000Mar 31, 2023
NEWEDGE ADVISORS, LLC--11100.00%2,000Mar 31, 2023

MyMD Pharmaceuticals's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 40.90K shares, valued at $70.35M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SHAY CAPITAL LLC----207,235-100.00%-Mar 31, 2023
MILLENNIUM MANAGEMENT LLC----68,312-100.00%-Mar 31, 2023
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC----67,000-100.00%-Mar 31, 2023
TWO SIGMA INVESTMENTS, LP----30,084-100.00%-Mar 31, 2023
WOLVERINE TRADING, LLC----19,600-100.00%-Mar 31, 2023
UBS GROUP AG----7,312-100.00%-Mar 31, 2023
IFP ADVISORS, INC----2-100.00%-Mar 31, 2023

MyMD Pharmaceuticals's largest sold out institutional shareholder by shares sold is SHAY CAPITAL LLC, sold -0.21M shares, valued at -, as of undefined.

MyMD Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD VALLEY FORGE FUNDS0.05%25,990--Dec 31, 2023
Cambria ETF Trust0.02%161,766-9,804-5.71%Jan 31, 2024
VANGUARD INDEX FUNDS0.00%1,807,659410,66629.40%Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%270,655--Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%26,030--Dec 31, 2023
FIDELITY CONCORD STREET TRUST0.00%126,191--Feb 29, 2024
SCHWAB CAPITAL TRUST0.00%13,965--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%142,387--Dec 31, 2023
EQ ADVISORS TRUST0.00%7,406--Dec 31, 2023
iSHARES TRUST0.00%84,695--Feb 29, 2024

MyMD Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 25.99K shares, compromising 0.05% of its total assets.

MyMD Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 222-
31 Mar, 211820.00%
31 Dec, 20157.14%
30 Sep, 201475.00%
30 Jun, 208-20.00%
31 Mar, 201042.86%
31 Dec, 197600.00%
30 Sep, 191-

As of 31 Mar 22, 2 institutions are holding MyMD Pharmaceuticals's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 225,600-
31 Mar, 211,166,571-8.80%
31 Dec, 201,279,111187.18%
30 Sep, 20445,401537.93%
30 Jun, 2069,820-80.78%
31 Mar, 20363,293-15.75%
31 Dec, 19431,21711.28%
30 Sep, 19387,520-

MyMD Pharmaceuticals (MYMD) has 5.60K shares outstanding as of 31 Mar 22, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 220.01%-
31 Mar, 213.14%26.48%
31 Dec, 203.44%239.44%
30 Sep, 201.20%3393.24%
30 Jun, 200.19%19.65%
31 Mar, 200.98%72.55%
31 Dec, 191.16%106.64%
30 Sep, 191.04%-

As of 31 Mar 22, MyMD Pharmaceuticals is held by 0.01% institutional shareholders, representing a 0.00% growth compared to 31 Mar 21.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 222-
31 Mar, 21912.50%
31 Dec, 208-27.27%
30 Sep, 2011175.00%
30 Jun, 204-33.33%
31 Mar, 206-
31 Dec, 196500.00%
30 Sep, 191-

2 institutional shareholders have increased their position in MYMD stock as of 31 Mar 22 compared to 9 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 22--
31 Mar, 212-
31 Dec, 202100.00%
30 Sep, 201-
30 Jun, 20--100.00%
31 Mar, 202100.00%
31 Dec, 191-
30 Sep, 19--

- institutional shareholders have reduced their position in MYMD stock as of 31 Mar 22 compared to 2 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 222-5,600-0.01%-2---
31 Mar, 211820.00%1,166,571-8.80%3.14%26.48%912.50%2-
31 Dec, 20157.14%1,279,111187.18%3.44%239.44%8-27.27%2100.00%
30 Sep, 201475.00%445,401537.93%1.20%3393.24%11175.00%1-
30 Jun, 208-20.00%69,820-80.78%0.19%19.65%4-33.33%--100.00%
31 Mar, 201042.86%363,293-15.75%0.98%72.55%6-2100.00%
31 Dec, 197600.00%431,21711.28%1.16%106.64%6500.00%1-
30 Sep, 191-387,520-1.04%-1---

MyMD Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 24, 2023Rivard Paulofficer Chief Legal OfficerP-PurchaseBuy150,000$1.11$166.50K400,000
Aug 18, 2023Rivard Paulofficer Chief Legal OfficerP-PurchaseBuy25,000$1.12$28.08K250,000
Dec 08, 2022Rivard Paulofficer EVP of Operations, GCP-PurchaseBuy10,000$1.53$15.30K225,000
Nov 29, 2021Silverman Joshuadirector-P-PurchaseBuy5,000$7.55$37.77K88,775
Nov 29, 2021Silverman Joshuadirector-P-PurchaseBuy3,266$7.09$23.17K83,775
Nov 29, 2021Silverman Joshuadirector-P-PurchaseBuy6,734$6.30$42.42K80,509
Nov 24, 2021Rivard Paulofficer EVP of Operations, GCP-PurchaseBuy15,000$6.03$90.45K215,000

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 24, 2023Rivard Paulofficer Chief Legal OfficerP-PurchaseBuy150,000$1.11$166.50K400,000
Aug 18, 2023Rivard Paulofficer Chief Legal OfficerP-PurchaseBuy25,000$1.12$28.08K250,000
Dec 08, 2022Rivard Paulofficer EVP of Operations, GCP-PurchaseBuy10,000$1.53$15.30K225,000
Nov 29, 2021Silverman Joshuadirector-P-PurchaseBuy5,000$7.55$37.77K88,775
Nov 29, 2021Silverman Joshuadirector-P-PurchaseBuy3,266$7.09$23.17K83,775
Nov 29, 2021Silverman Joshuadirector-P-PurchaseBuy6,734$6.30$42.42K80,509
Nov 24, 2021Rivard Paulofficer EVP of Operations, GCP-PurchaseBuy15,000$6.03$90.45K215,000

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 16, 2024Glass Mitchelldirector Buy----
Aug 24, 2023Rivard Paulofficer Chief Legal OfficerP-PurchaseBuy150,000$1.11$166.50K400,000
Aug 18, 2023Rivard Paulofficer Chief Legal OfficerP-PurchaseBuy25,000$1.12$28.08K250,000
Jun 09, 2023Chapman Christopher C JRdirector, officer President, Chief Med. OfficerA-AwardBuy300,000$1.66$498.00K300,000
Jun 09, 2023Kaplin Adamofficer Chief Scientific OfficerA-AwardBuy150,000$1.66$249.00K150,000
Jun 09, 2023Uzonwanne Judedirector-A-AwardBuy150,000$1.66$249.00K150,000
Jun 09, 2023Schreiber Christopher Cdirector-A-AwardBuy150,000$1.66$249.00K150,000
Jun 09, 2023EAGLE CRAIGdirector-A-AwardBuy475,000$1.66$788.50K475,000
Jun 09, 2023Silverman Joshuadirector-A-AwardBuy200,000$1.66$332.00K200,000
Jun 09, 2023White Billy Joedirector-A-AwardBuy150,000$1.66$249.00K150,000
Jun 09, 2023Rivard Paulofficer Chief Legal OfficerA-AwardBuy150,000$1.66$249.00K150,000
Apr 05, 2023Chapman Christopher C JRdirector, officer President, Chief Med. OfficerA-AwardBuy750,000$1.55$1.16M750,000
Dec 08, 2022Rivard Paulofficer EVP of Operations, GCP-PurchaseBuy10,000$1.53$15.30K225,000
Nov 29, 2021Silverman Joshuadirector-P-PurchaseBuy5,000$7.55$37.77K88,775
Nov 29, 2021Silverman Joshuadirector-P-PurchaseBuy3,266$7.09$23.17K83,775
Nov 29, 2021Silverman Joshuadirector-P-PurchaseBuy6,734$6.30$42.42K80,509
Nov 24, 2021Rivard Paulofficer EVP of Operations, GCP-PurchaseBuy15,000$6.03$90.45K215,000
Oct 15, 2021Kaplin Adamofficer Chief Scientific OfficerA-AwardBuy600,000--600,000
Oct 15, 2021Schreiber Christopher Cdirector-A-AwardBuy150,000--150,000
Oct 15, 2021White Billy Joedirector-A-AwardBuy150,000--150,000

The last insider buy of MYMD was made by Rivard Paul on Aug 24 2023, buying 150,000 shares at $1.11 per share (worth $166.50K).

MyMD Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20232--
Q2 20239--
Q4 20221--
Q4 202112--
Q2 2021129133.33%
Q1 2021---
Q3 20204--
Q1 202061600.00%
Q4 201913--
Q3 20192--
Q2 20191--
Q1 20194--
Q4 20181--
Q3 2018---
Q2 2018---
Q4 20173--
Q3 2017---
Q4 2016---
Q2 20167--
Q1 20161--

2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by MyMD Pharmaceuticals's insiders, as of Q3 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20232--
Q2 2023---
Q4 20221--
Q4 20214--
Q2 2021---
Q1 2021---
Q3 2020---
Q1 2020-1-
Q4 201912--
Q3 2019---
Q2 2019---
Q1 2019---
Q4 2018---
Q3 2018---
Q2 2018---
Q4 2017---
Q3 2017---
Q4 2016---
Q2 20165--
Q1 20161--

As of Q3 2023, Insider owners conducted 2 open market buy trades and 0 open market sell trades of MyMD Pharmaceuticals's stocks.

MyMD Pharmaceuticals Peer Ownership


TickerCompany
SRZNSurrozen, Inc.
DSGNDesign Therapeutics, Inc.
AVIRAtea Pharmaceuticals, Inc.
NVCTNuvectis Pharma, Inc.
KROSKeros Therapeutics, Inc.
ORICORIC Pharmaceuticals, Inc.
PASGPassage Bio, Inc.
LGNDLigand Pharmaceuticals Incorporated
GOSSGossamer Bio, Inc.
XBIOXenetic Biosciences, Inc.
YS331
REVBRevelation Biosciences, Inc.
LRMRLarimar Therapeutics, Inc.
GOVXGeoVax Labs, Inc.
RXRXRecursion Pharmaceuticals, Inc.
LYELLyell Immunopharma, Inc.
BOLTBolt Biotherapeutics, Inc.
KZRKezar Life Sciences, Inc.
UBXUnity Biotechnology, Inc.
EXAIExscientia plc
LYRALyra Therapeutics, Inc.
KRONKronos Bio, Inc.
REPLReplimune Group, Inc.

MYMD Ownership FAQ


MyMD Pharmaceuticals is owned by institutional shareholders (0.01%), insiders (6.85%), and public (93.14%). The largest institutional shareholder of MyMD Pharmaceuticals is VANGUARD GROUP INC (32.80% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.05% of total shares).

MyMD Pharmaceuticals's major institutional shareholders are VANGUARD GROUP INC, MIRAE ASSET GLOBAL INVESTMENTS CO., LTD., GEODE CAPITAL MANAGEMENT, LLC, BLACKROCK INC., and STATE STREET CORP. The top five shareholders own together 72.72% of the company's share outstanding.

As of Mar 2022, there are 2 institutional shareholders of MyMD Pharmaceuticals.

VANGUARD GROUP INC owns 1.46M shares of MyMD Pharmaceuticals, representing 32.80% of the company's total shares outstanding, valued at $2.51B (as of Mar 2023).

As of Mar 2023, MIRAE ASSET GLOBAL INVESTMENTS CO., LTD holds 1.17M shares of MyMD Pharmaceuticals (MYMD), compromising 26.40% of the company, valued at $2.02B.

GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of MyMD Pharmaceuticals. The company owns 276.3K of the company's shares outstanding (worth $475.23M).